Gritstone Oncology Inc buy Piper Sandler
Start price
28.09.23
/
50%
€1.42
Target price
28.09.24
€6.63
Performance (%)
-63.33%
End price
29.09.24
€0.52
Summary
This prediction ended on 29.09.24 with a price of €0.52. The BUY prediction by Piper_Sandler for Gritstone Oncology Inc performed very badly with a performance of -63.33%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Gritstone Oncology Inc | -64.075% | -64.075% | -89.963% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Piper_Sandler for this prediction
In the thread Gritstone Oncology Inc diskutieren
Gritstone bio, Inc. (NASDAQ: GRTS) had its price target raised by analysts at Piper Sandler from $6.00 to $7.00. They now have an "overweight" rating on the stock.
Ratings data for GRTS provided by MarketBeat
In the thread Trading Gritstone Oncology Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten